JPMorgan Chase & Co’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.35M | Buy |
390,364
+19,405
| +5% | +$266K | ﹤0.01% | 2653 |
|
|
2025
Q1 | $4.1M | Buy |
370,959
+349,845
| +1,657% | +$3.87M | ﹤0.01% | 2804 |
|
|
2024
Q4 | $225K | Sell |
21,114
-46,948
| -69% | -$500K | ﹤0.01% | 4489 |
|
|
2024
Q3 | $864K | Buy |
68,062
+49,318
| +263% | +$626K | ﹤0.01% | 3725 |
|
|
2024
Q2 | $315K | Buy |
18,744
+1,078
| +6% | +$18.1K | ﹤0.01% | 4057 |
|
|
2024
Q1 | $265K | Sell |
17,666
-6,278
| -26% | -$94.2K | ﹤0.01% | 4309 |
|
|
2023
Q4 | $359K | Buy |
23,944
+4,901
| +26% | +$73.5K | ﹤0.01% | 4090 |
|
|
2023
Q3 | $267K | Sell |
19,043
-32,174
| -63% | -$451K | ﹤0.01% | 4062 |
|
|
2023
Q2 | $530K | Sell |
51,217
-9,174
| -15% | -$95K | ﹤0.01% | 3729 |
|
|
2023
Q1 | $558K | Buy |
60,391
+59,695
| +8,577% | +$552K | ﹤0.01% | 3766 |
|
|
2022
Q4 | $6K | Sell |
696
-51,982
| -99% | -$448K | ﹤0.01% | 5197 |
|
|
2022
Q3 | $438K | Buy |
52,678
+38,619
| +275% | +$321K | ﹤0.01% | 3825 |
|
|
2022
Q2 | $116K | Sell |
14,059
-67,808
| -83% | -$559K | ﹤0.01% | 4568 |
|
|
2022
Q1 | $714K | Buy |
81,867
+19,280
| +31% | +$168K | ﹤0.01% | 3802 |
|
|
2021
Q4 | $595K | Sell |
62,587
-2,426
| -4% | -$23.1K | ﹤0.01% | 3962 |
|
|
2021
Q3 | $1.09M | Sell |
65,013
-20,719
| -24% | -$349K | ﹤0.01% | 3549 |
|
|
2021
Q2 | $1.31M | Sell |
85,732
-12,425
| -13% | -$190K | ﹤0.01% | 3485 |
|
|
2021
Q1 | $1.91M | Buy |
98,157
+13,175
| +16% | +$257K | ﹤0.01% | 3269 |
|
|
2020
Q4 | $1.53M | Sell |
84,982
-17,676
| -17% | -$319K | ﹤0.01% | 3132 |
|
|
2020
Q3 | $1.98M | Sell |
102,658
-10,379
| -9% | -$201K | ﹤0.01% | 2765 |
|
|
2020
Q2 | $2.95M | Sell |
113,037
-17,411
| -13% | -$455K | ﹤0.01% | 2482 |
|
|
2020
Q1 | $2.33M | Sell |
130,448
-13,494
| -9% | -$241K | ﹤0.01% | 2506 |
|
|
2019
Q4 | $4.8M | Buy |
143,942
+124,924
| +657% | +$4.17M | ﹤0.01% | 2190 |
|
|
2019
Q3 | $453K | Buy |
19,018
+13,872
| +270% | +$330K | ﹤0.01% | 3390 |
|
|
2019
Q2 | $170K | Buy |
+5,146
| New | +$170K | ﹤0.01% | 3821 |
|
|
2018
Q4 | – | Sell |
-6,778
| Closed | -$320K | – | 4991 |
|
|
2018
Q3 | $320K | Buy |
+6,778
| New | +$320K | ﹤0.01% | 3691 |
|
|
2018
Q2 | – | Sell |
-2,073
| Closed | -$103K | – | 4852 |
|
|
2018
Q1 | $103K | Sell |
2,073
-2,887
| -58% | -$143K | ﹤0.01% | 3920 |
|
|
2017
Q4 | $185K | Sell |
4,960
-211
| -4% | -$7.87K | ﹤0.01% | 3692 |
|
|
2017
Q3 | $168K | Buy |
+5,171
| New | +$168K | ﹤0.01% | 3499 |
|